Skip to Content

Methylphenidate Extended-Release Oral Suspension and Chewable Tablets

Last Updated: September 14, 2018
Status: Current

Products Affected - Description
    • Quillivant XR oral powder for suspension, Pfizer, 5 mg/mL, 120 mL bottle, NDC 24478-0200-20
    • Quillivant XR oral powder for suspension, Pfizer, 5 mg/mL, 150 mL bottle, NDC 24478-0205-25
    • Quillivant XR oral powder for suspension, Pfizer, 5 mg/mL, 180 mL bottle, NDC 24478-0210-30
    • Quillivant XR oral powder for suspension, Pfizer, 5 mg/mL, 60 mL bottle, NDC 24478-0190-10
Reason for the Shortage
    • Pfizer has Quillivant XR on shortage due to manufacturing delays.
    • Pfizer has QuillChew ER chewable tablets available.
Available Products
    • QuilliChews chewable tablet, Pfizer, 20 mg, bottle, 100 count, NDC 24478-0120-01
    • QuilliChews chewable tablet, Pfizer, 30 mg, bottle, 100 count, NDC 24478-0130-01
    • QuilliChews chewable tablet, Pfizer, 40 mg, bottle, 100 count, NDC 24478-0140-01

Estimated Resupply Dates

    • Pfizer has Quillivant XR 5 mg/mL extended-release oral suspension in 60 mL bottles,120 mL bottles, 150 mL bottles, and 180 mL bottles on back order and the company cannot estimate a release date. There is limited supply of short-dated 180 mL bottles with an expiration date of March 2019.

Updated

Updated September 14, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 6, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide